Comparison of pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma

Trial Profile

Comparison of pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Dec 2011

At a glance

  • Drugs Bortezomib; Bortezomib
  • Indications Multiple myeloma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Jun 2007 Results have been reported.
    • 12 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top